What Are the Implications of Liquid Biopsies in Breast Cancer Management?
Liquid biopsies, which analyze circulating tumor DNA (ctDNA) in the blood, offer a non-invasive method for detecting and monitoring breast cancer. These tests can provide real-time insights into the genetic changes occurring in a tumor, allowing for the early detection of recurrence and the assessment of treatment efficacy. Liquid biopsies are particularly valuable for tracking the evolution of cancer and adapting treatment plans accordingly.
